Abstract:Objective To study the influence of human leucocyte antigen(HLA) and major his-tocompatibility complex class Ⅰ chain-related gene A (MICA) specific antibodies on renal allograft function and graft rejective reaction by monitoring their changes from preoperative to postoperative pe-riods. Methods Twenty-seven patients with renal aliografts were tested with the specificity of anti-HLA antibodies (anti-HLA class Ⅰ and anti-HLA class Ⅱ) and anti-MICA antibodies and their posi-tive value changes by flow PRATM beads. The HLA genotype was integrated to distinguish donor specific antibody(DSA) and non-donor specific antibody(NDSA). Their serum creatinine levels and clinical data were analyzed simultaneously. Results Of the 27 patients, 22 cases accepted renal transplantation from dead bodies and 5 eases accepted from live donors. Except 1 failed patient, the other 26 patients had good functional renal allografts. Twenty-four survival patients were followed up on month 1, 3, 6 and 12 after transplantation. Seven out of 27 patients had pre-exist antibody before transplantation. Among them, 2 patients had anti-HLA antibody; 3 patients had anti-MICA antibody; 2 patients had both anti-HLA and anti-MICA antibody. Three patients with no anti-HLA and anti-MICA antibodies before transplantation created antibodies after transplantation from 3 to 6 months. One patient created NDSA after transplantation and appeared chronic rejection. There were 3 patients who had anti-MICA antibodies before transplantation. The expression levels of antibodies had changed from high to low, but the specific anti-MICA antibody had not changed during the follow-up on month 1, 3, 6 and 12 after transplantation. The patient with pre-transplantation low level of anti-HLA class Ⅱ antibody appeared acute rejection with fever and his CMV was positive as well. The patient's SCr levels changed from 171 μmol/L to 236 μmol/L after I to 3 months post-transplantation. Twenty-four patients were divided into positive and negative groups according to the specific antibody. There was significant difference of SCr levels between the 2 groups 1 month and 1 year after transplantation(P= 0.03, 0.05). Conclusions It is important to detect the specificity and positive value of anti-HLA antibodies and anti-MICA antibody regularly during the post transplantation follow-up. This will make an effective therapy for decreasing the occurrenee and development of acute or chronic rejection and hy-pofunction on renal allograft.

The epitope analysis of HLA class-Ispecific antibody in highly sensitized renal transplant recipients

Detection of Sensitization to HLA Antigens in Long-Term Renal Transplant Recipients and Its Clinical Implication

Prevalence of anti-HLA antibodies in highly sensitized kidney transplant candidates

Clinical management of kidney transplantation in highly sensitized recipients

Good HLA matching can improve the transplant results in PRA hypersensitivity recipients

The detection of panel reactive antibody in kidney transplantation

The analysis of the factors inducing HLA sensitization in first renal transplant recipients

High-PRA mediates delayed hyperacute rejection after renal transplantation

Factors resulting in HLA humoral sensitization in candidates of renal recipients

Management experience and effect analysis of highly sensitized recipients before living kidney transplantation

Significance of HLA-amino acid residue matching in renal transplantation of sensitized recipients

Superiority of Single-Antigen Bead Study in Donor-Specific Antibodies: Determination in Highly Sensitized Patients.

Dynamic Analysis of the HLA and MICA Specific Antibody Effect on Renal Allograft Fnnetion

Pre-transplant Impact Factors of Acute Rejection after Kidney Transplantation

Issues of Immunological and Hemodynamic Monitoring Before and During Kidney Transplantation in Sensitized Heart Transplant Recipient

Impact of HLA Antibodies on Renal Transplant Patients

Impairment of Renal Allograft Function by Post-Transplant Anti-Hla Antibodies

Post-transplantation Antibody Monitoring and HLA Antibody Epitope Identification

Application of Detection of HLA Antibody by ELISA in Renal Transplantation

Analysis of HLA Mismatch Rate Between the Recipients and the Donors in 36 Kidney Transplantation Centers

Effect of High Dose Immunoglobulin on the Panel Reactive Antibody